AJMC November 15, 2024
Kennedy Ferruggia

Respiratory syncytial virus (RSV) vaccination is approximately 77% to 81% effective against hospital and emergency department encounters among older adults, study finds.

This article was originally published on Pharmacy Times®.

A new study findings published in The Lancet assessed the effectiveness of respiratory syncytial virus (RSV) vaccines against RSV-associated hospitalizations and emergency department encounters among individuals at least 60 years of age. The study was conducted to confirm RSV vaccine effectiveness found in clinical trials against lower respiratory tract disease using real world data.1

According to the CDC, the US experiences up to 160,000 hospitalizations and around 10,000 deaths among older adults due to RSV infection each year. Symptoms typically present like a mild cold but could become more severe...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Govt Agencies, Health System / Hospital, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
Related Articles:
Surgeon general says U.S. smoking rates have tumbled, but not for everyone
Research highlights disparities in heart disease, stroke trends worldwide
Suicide is NOT a Symptom: Healthcare Is Missing the Mark on Suicide Prevention
Community Pharmacies Hold Key Role in Protecting Older Adults From RSV
Study Finds Nearly 75% of Adults 25 and Older Have Overweight or Obesity

Share This Article